Bharat Rasayan Board To Meet On Oct 24, Bonus & Stock Split On The Cards; Buy Now?

One of the top producers of agrochemicals in India, Bharat Rasayan Limited, has declared that its Board of Directors would convene on October 24, 2025, to discuss key corporate actions aimed at rewarding shareholders. Since such actions frequently seek to improve liquidity and increase retail participation, this development has aroused investor attention.

"We wish to inform that a meeting of the Board of Directors of Bharat Rasayan Limited ("the Company") is scheduled to be held on Friday, October 24, 2025, to consider interalia, the proposal of Sub-Division of equity shares and proposal for issuance of Bonus issue of Equity Shares of the Company," said Bharat Rasayan in a stock exchange filing on October 18.

Meanwhile, the trading window for insiders stays closed until 48 hours following the release of the company's Q2 FY26 financial results. Market observers are eagerly awaiting the conclusion of this board meeting, which might potentially increase Bharat Rasayan's share price momentum in the coming sessions.

Commenting on the share price outlook, A R Ramachandran, Independent SEBI-registered Research Analyst, said, "Bharat Rasayan stock price is bearish on the Daily charts with strong resistance at 11000. A Daily close below support of 10450 could lead to a target of 9445 in the near term."

Bharat Rasayan is an Indian firm founded in 1989 that develops agricultural-grade pesticides and intermediates for the agrochemical sector. It has two production units, one in Mokhra (Haryana) and another in Dahej (Gujarat).

From a financial aspect, the firm has demonstrated modest long‐term growth: over ten years it achieved a compounded sales growth of roughly 10% and profit growth of around 14% as per the statistics of Screener. However, during the previous five years, the performance has been poorer, with sales actually slightly negative (-0.7%) and profit growth negative over the 3-year and 5-year periods (-13% and -6% respectively), while the trailing twelve months (TTM) show a turnaround with profit growth of ~42%.

On the return front, ROE has declined in recent years: 10-year ROE ~20%, 5-year ~16%, 3-year ~12% and last year ~11%, as per Screener. With a current debt-free status the stock trades at a P/E of ~29.2 and a book value of about Rs 2,663 per share (face value Rs 10).

"The stock is sustaining above ₹11,000, indicating strong support and accumulation at lower levels. Momentum remains bullish with potential to test ₹11,600-₹11,800 on further strength. RSI stays positive, supporting a continued uptrend in the near term," commented Riyank Arora, technical analyst at Mehta Equities Ltd.

Disclaimer

The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.